INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 443m ago
House PTR43m ago
SEC 13F42m ago
Robinhood Chain42m ago

Results

21,218 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$156K
1,200 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

Page 529 of 531
← PrevNext →
28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL
$79K
600 sh
Nov 3, 2025
Nov 5, 2025
traded Nov 3, 2025
+2d
SEC Form 4

Evidence

28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$156K
1,200 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
1,509 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

28
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$104K
800 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

26
WT
Watanabe ToddDirector, See Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$284K
11.5K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

26
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$171
292 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

25
FA
Fang AndyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$40K
160 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

25
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

25
HL
Heeson LeeEVP, Head of Incyte Intl
INCYINCYTE CORP
Open-market sale · 10b5-1 plan
SELL$289K
3,074 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

25
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

24
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.39M
596.4K sh
Nov 5, 2025Nov 5, 2025
traded Nov 5, 2025
+0dSEC Form 4

Evidence

24
YG
Yarbrough Timothy G.EVP, Chief Financial Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$25K
6,069 sh
Nov 5, 2025Nov 5, 2025
traded Nov 5, 2025
+0dSEC Form 4

Evidence

24
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$1.26M
6,202 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

23
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$177K
7,165 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

23
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
2,607 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

23
SH
Shulman Douglas H.Director, President & CEO
OMFOneMain Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$2.08M
35.0K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

23
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$1.39M
7,619 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

23
QM
Quigley Jill M.Director
TERNTerns Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$441K
24.5K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

22
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
5,000 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
WM
Wensveen MaartenEVP & Chief Technology Officer
CMPRCIMPRESS plc
Open-market sale
SELL$37K
526 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$792K
3,834 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$750K
3,667 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$820K
3,992 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
SS
Singh SumitDirector, Chief Executive Officer
CHWYChewy, Inc.
Open-market sale · 10b5-1 plan
SELL$533K
16.3K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$467K
2,305 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$742K
4,032 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$676K
3,636 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
PM
Palasis MariaDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$35K
1,287 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC Form 4

Evidence

20
VL
Vairavan LathaSVP Chief Financial Officer
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2,175
88 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$783K
4,286 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$600K
3,243 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
WT
Watanabe ToddDirector, See Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1,753
69 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$381
15 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1,092
43 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
HC
Howse CurtisSee remarks
SYFSynchrony Financial
Open-market sale · 10b5-1 plan
SELL$895K
12.1K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
1,368 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC Form 4

Evidence

20
HR
Howard Justyn RussellDirector, Executive Chair, 10% Owner
SPTSprout Social, Inc.
Open-market sale · 10b5-1 plan
SELL$204K
20.0K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

20
RM
Rothberg Jonathan MDirector, 10% Owner
BFLYButterfly Network, Inc.
Open-market sale · 10b5-1 plan
SELL$309K
100.5K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$513K
30.0K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence